Review of the Results of WT1 Peptide Vaccination Strategies for Myelodysplastic Syndromes and Acute Myeloid Leukemia from Nine Different Studies

We performed a systematic review of data from nine clinical trials of WT1 peptide vaccination in patients with myelodysplastic syndromes and/or acute myeloid leukemia (MDS/AML), published between 2004 and 2012. A total of 51 patients were eligible for analysis. Vaccination with WT1 peptides proved s...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Stasi, Antonio, Jimenez, Antonio M., Minagawa, Kentaro, Al-Obaidi, Mustafa, Rezvani, Katayoun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2015
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4316779/
https://www.ncbi.nlm.nih.gov/pubmed/25699052
http://dx.doi.org/10.3389/fimmu.2015.00036

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4316779/
https://www.ncbi.nlm.nih.gov/pubmed/25699052
http://dx.doi.org/10.3389/fimmu.2015.00036

Ejemplares similares